Molecular Glue Labs

Ternary Therapeutics

This company develops an artificial intelligence platform to design molecular glue therapeutics for healthcare providers and pharmaceutical partners to treat complex diseases.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Ternary Tx

Ternary Therapeutics develops an artificial intelligence platform to design molecular glue drugs for pharmaceutical companies targeting previously undruggable proteins linked to inflammatory diseases.

Celeris Therapeutics

The company develops artificial intelligence software to design and discover protein degrader drugs for pharmaceutical and biotechnology organisations.

Chai Discovery

This company develops artificial intelligence models to predict and design molecular structures and protein binders for pharmaceutical and life sciences researchers.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

DreamFold AI

This company develops generative artificial intelligence models for protein design to discover medicines for pharmaceutical and biotechnology researchers.

TRIANA Biomedicines

This company develops molecular glue therapeutics for patients with cancer and other diseases using a discovery platform and computational tools.